DAUNOrubicin and Cytarabine and Recombinate
Determining the interaction of DAUNOrubicin and Cytarabine and Recombinate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: cytarabine liposomal / daunorubicin liposomal
Brand name: Vyxeos
Synonyms: Cytarabine and daunorubicin (liposomal), Daunorubicin and Cytarabine (Liposomal)
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Recombinate (recombinant)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- DAUNOrubicin and Cytarabine-Recombinate recombinant
- DAUNOrubicin and Cytarabine-Recombivax
- DAUNOrubicin and Cytarabine-Recombivax HB
- DAUNOrubicin and Cytarabine-Recombivax HB Adult
- DAUNOrubicin and Cytarabine-Recombivax HB Dialysis Formulation
- DAUNOrubicin and Cytarabine-Recombivax HB Pediatric/Adolescent
- Recombinate-Daunorubicin and Cytarabine (Liposomal)
- Recombinate-Daunorubicin and cytarabine liposome Intravenous
- Recombinate-Daunorubicin citrate
- Recombinate-Daunorubicin citrate liposome Intravenous
- Recombinate-Daunorubicin hydrochloride
- Recombinate-Daunorubicin Intravenous